PATENT CLAIM ANALYSIS

Application Number: 15745789
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "655000"]

Abstract:
Methods for increasing susceptibility of cancer cells to immunotherapeutic agents and methods for assessing the effectiveness of a cancer treatment.

Claim (Index 27):
The method according to  claim 26 , wherein the CaSR activator agent is a CaSR allosteric activator selected the group consisting of from cinacalcet, NPS-R568, calindol, calcimimetic B, AC-265347 and combinations thereof.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 86.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10485351', '15616672', '14926372', '14346693', '15253307']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.772944198196057
- 35 USC 102 Novelty (BERT): 0.5150712376889302
- Combined Prediction Score: 0.7471569021453442
- Mean Citation Score: 195.007452
- Max Citation Score: 224.70102000000003
- Similarity Product: 118.96320029430628

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test